Caris Life Sciences and ConcertAI Form Broad Partnership Creating Industry-Leading Molecular Oncology Research Platform to Accelerate Drug Development and Novel Research

The Combination of Comprehensive Genomic Profiling with Reference-standard Clinical Data Establishes an Unmatched Translational and Clinical Development Research Platform IRVING, Texas and CAMBRIDGE, Mass., Jan. 9, 2023 /PRNewswire/ — Caris Life Sciences®(Caris), the leading molecular...

ConcertAI’s TeraRecon Expands AI, Partner, and Advanced Imaging Solutions at #RSNA22, Helping Clinicians Improve Efficiency and Care with Next Generation Eureka Clinical AI Platform

CAMBRIDGE, Mass., Nov. 28, 2022 /PRNewswire/ — ConcertAI’s TeraRecon, a leader in advanced visualization and artificial intelligence (AI) for medical imaging, recently unveiled first-in-category capabilities in advanced visualization, AI, and an AI solutions...